Citigroup’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-39
| Closed | – | – | 5060 |
|
|
2017
Q1 | $0 | Sell |
39
-1,065
| -96% | – | ﹤0.01% | 4970 |
|
|
2016
Q4 | $6K | Buy |
+1,104
| New | +$6K | ﹤0.01% | 4629 |
|
|
2016
Q3 | – | Sell |
-1,200
| Closed | -$7K | – | 5048 |
|
|
2016
Q2 | $7K | Sell |
1,200
-18,319
| -94% | -$107K | ﹤0.01% | 4639 |
|
|
2016
Q1 | $86K | Buy |
19,519
+18,318
| +1,525% | +$80.7K | ﹤0.01% | 4013 |
|
|
2015
Q4 | $7K | Sell |
1,201
-123
| -9% | -$717 | ﹤0.01% | 4883 |
|
|
2015
Q3 | $10K | Sell |
1,324
-892
| -40% | -$6.74K | ﹤0.01% | 4404 |
|
|
2015
Q2 | $14K | Buy |
2,216
+516
| +30% | +$3.26K | ﹤0.01% | 4447 |
|
|
2015
Q1 | $14K | Sell |
1,700
-160
| -9% | -$1.32K | ﹤0.01% | 4610 |
|
|
2014
Q4 | $9K | Sell |
1,860
-205
| -10% | -$992 | ﹤0.01% | 4891 |
|
|
2014
Q3 | $11K | Sell |
2,065
-230
| -10% | -$1.23K | ﹤0.01% | 4598 |
|
|
2014
Q2 | $18K | Sell |
2,295
-81
| -3% | -$635 | ﹤0.01% | 4242 |
|
|
2014
Q1 | $17K | Buy |
2,376
+54
| +2% | +$386 | ﹤0.01% | 4585 |
|
|
2013
Q4 | $14K | Sell |
2,322
-378
| -14% | -$2.28K | ﹤0.01% | 4738 |
|
|
2013
Q3 | $20K | Sell |
2,700
-873
| -24% | -$6.47K | ﹤0.01% | 4291 |
|
|
2013
Q2 | $14K | Buy |
+3,573
| New | +$14K | ﹤0.01% | 4339 |
|